New Chemotherapy Agent LiPyDau Overcomes Drug-Resistant Cancer
Researchers have developed a groundbreaking new chemotherapeutic agent, LiPyDau, which shows remarkable efficacy against multiple tumor types in preclinical studies.
A research team led by the Medical University of Vienna, the HUN-REN Research Centre for Natural Sciences and the Eötvös Loránd University in Budapest has developed LiPyDau.
Published in the leading journal Molecular Cancer, the study introduces a highly promising strategy for tackling drug-resistant cancers.
Chemotherapy remains a cornerstone of cancer treatment despite well-known challenges, including toxic side effects and drug resistance.
No direct quote available in the text.
Author's summary: LiPyDau is a new chemotherapy agent.
More News
- The Middle East’s Axis of Rape and Pillage
- NYT Mini crossword answers, hints for October 31, 2025
- Healthcare Providers Describe Exclusive Human Milk Diet as 'Critical' Need for Premature Infants
- Align Your Day With Nature's Clock for a Stronger, Healthier Heart
- Invisible Assaults: How India’s crime data erases violence against women and children | SabrangIndia